Press releases
November 14, 2011
Digna Biotech regains all rights to Disitertide (P144) to treat skin conditions
More information
September 21, 2011
FDA Grants Cardiotrophin-1 Orphan Drug Status for Acute Liver Failure Treatment
More information
September 13, 2011
Cardiotrophin 1 shows promising results for treatment of obesity and metabolic syndrome
More information
August 4, 2011
Cardiotrophin-1, a protein that removes fat from adipose tissue and reduces body weight
More information
June 28, 2011
Flamel Technologies and Digna Biotech Announce Multiple Product Development Agreement
More information
March 11, 2011
Cardiotrophin-1 starts a phase I clinical trial in healthy volunteers
More information
February 3, 2011
Digna Biotech and CIMA Receive Euros 1.3 Million Funding for AIPGene Therapy
More information
© Digna Biotech · Legal information · Company associated to ASEBIO 